IT1229531B - Composti nucleosidi dideossidideidrocarbociclici e formulazione farmaceutica che li contiene - Google Patents

Composti nucleosidi dideossidideidrocarbociclici e formulazione farmaceutica che li contiene

Info

Publication number
IT1229531B
IT1229531B IT8947546A IT4754689A IT1229531B IT 1229531 B IT1229531 B IT 1229531B IT 8947546 A IT8947546 A IT 8947546A IT 4754689 A IT4754689 A IT 4754689A IT 1229531 B IT1229531 B IT 1229531B
Authority
IT
Italy
Prior art keywords
dideoxide
hydrocarbocyclic
nucleosid
compounds
pharmaceutical formulation
Prior art date
Application number
IT8947546A
Other languages
English (en)
Italian (it)
Other versions
IT8947546A0 (it
Inventor
Vince Robert
Hua Mei
Leslie Myers Peter
Storer Richard
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/146,252 external-priority patent/US4916224A/en
Priority claimed from GB888821011A external-priority patent/GB8821011D0/en
Priority claimed from US07/278,652 external-priority patent/US4931559A/en
Application filed by Univ Minnesota filed Critical Univ Minnesota
Publication of IT8947546A0 publication Critical patent/IT8947546A0/it
Application granted granted Critical
Publication of IT1229531B publication Critical patent/IT1229531B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IT8947546A 1988-01-20 1989-01-19 Composti nucleosidi dideossidideidrocarbociclici e formulazione farmaceutica che li contiene IT1229531B (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/146,252 US4916224A (en) 1988-01-20 1988-01-20 Dideoxycarbocyclic nucleosides
GB888821011A GB8821011D0 (en) 1988-09-07 1988-09-07 Chemical compounds
US07/278,652 US4931559A (en) 1988-01-20 1988-12-05 Optically-active isomers of dideoxycarbocyclic nucleosides

Publications (2)

Publication Number Publication Date
IT8947546A0 IT8947546A0 (it) 1989-01-19
IT1229531B true IT1229531B (it) 1991-09-04

Family

ID=27264063

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8947546A IT1229531B (it) 1988-01-20 1989-01-19 Composti nucleosidi dideossidideidrocarbociclici e formulazione farmaceutica che li contiene

Country Status (29)

Country Link
JP (1) JP2793825B2 (xx)
KR (1) KR0127137B1 (xx)
AT (1) AT397801B (xx)
AU (2) AU626278B2 (xx)
BE (1) BE1003815A4 (xx)
CA (1) CA1339896C (xx)
CH (1) CH679152A5 (xx)
DE (1) DE3901502C2 (xx)
DK (1) DK175131B1 (xx)
ES (1) ES2010091A6 (xx)
FI (1) FI93546C (xx)
FR (1) FR2626002B1 (xx)
GB (1) GB2217320B (xx)
GR (1) GR890100033A (xx)
HU (1) HU203755B (xx)
IE (1) IE62275B1 (xx)
IL (1) IL88999A (xx)
IT (1) IT1229531B (xx)
LU (1) LU87437A1 (xx)
MY (1) MY103801A (xx)
NL (1) NL8900122A (xx)
NO (1) NO169123C (xx)
NZ (1) NZ227663A (xx)
OA (1) OA09031A (xx)
PL (1) PL163814B1 (xx)
PT (1) PT89482B (xx)
RU (1) RU2114846C1 (xx)
SE (1) SE505213C2 (xx)
YU (1) YU47791B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1215339B (it) * 1987-01-14 1990-02-08 Co Pharma Corp Srl Procedimento per la preparazione di 9-(idrossialchil)-ipoxantine
US5631370A (en) 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
US4939252A (en) * 1989-04-20 1990-07-03 Hoffmann-La Roche Inc. Novel intermediates for the preparation of Carbovir
DE69033252T2 (de) * 1989-06-27 1999-12-09 The Wellcome Foundation Ltd., Greenford Therapeutische nukleoside
GB8916477D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916479D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916478D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916480D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
US5126452A (en) * 1990-04-06 1992-06-30 Glaxo Inc. Synthesis of purine substituted cyclopentene derivatives
US5241069A (en) * 1990-04-06 1993-08-31 Glaxo Inc. Carbonate intermediates for the synthesis of purine substituted cyclopentene derivatives
US5144034A (en) * 1990-04-06 1992-09-01 Glaxo Inc. Process for the synthesis of cyclopentene derivatives of purines
US5057630A (en) * 1990-04-06 1991-10-15 Glaxo Inc. Synthesis of cyclopentene derivatives
GB9108376D0 (en) * 1991-04-19 1991-06-05 Enzymatix Ltd Cyclopentenes
AU677732B2 (en) * 1993-11-12 1997-05-01 Merrell Pharmaceuticals Inc. 6-oxo-nucleosides useful as immunosuppressants
GB9721780D0 (en) * 1997-10-14 1997-12-10 Glaxo Group Ltd Process for the synthesis of chloropurine intermediates
HU227559B1 (en) * 1998-10-30 2011-08-29 Lonza Ag Method for producing 4-[(2',5'-diamino-6'-halopyrimidine-4'-yl)amino]-cyclopent-2-enylmethanols
US6433170B1 (en) 1998-10-30 2002-08-13 Lonza Group Method for producing 4-[2',5'-diamino-6'-halopyrimidine-4'-yl)amino]- cyclopent-2-enylmethanols
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
GB9903091D0 (en) * 1999-02-12 1999-03-31 Glaxo Group Ltd Therapeutic nucleoside compound
AR039540A1 (es) * 2002-05-13 2005-02-23 Tibotec Pharm Ltd Compuestos microbicidas con contenido de pirimidina o triazina
TW202019942A (zh) 2018-07-27 2020-06-01 日商富士軟片股份有限公司 環戊烯嘌呤衍生物或其鹽
JP2023519882A (ja) 2020-03-27 2023-05-15 ソム、イノベーション、バイオテック、ソシエダッド、アノニマ シヌクレイノパチーの治療に有用な化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268672A (en) * 1977-02-09 1981-05-19 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
US4742064A (en) * 1985-09-10 1988-05-03 Regents Of The University Of Minnesota Antiviral carbocyclic analogs of xylofuranosylpurines
JPS62177234A (ja) * 1986-01-30 1987-08-04 Mitsubishi Heavy Ind Ltd 遠心紡糸によるカ−ボン繊維の製造装置
IN164556B (xx) * 1986-03-06 1989-04-08 Takeda Chemical Industries Ltd
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.

Also Published As

Publication number Publication date
KR0127137B1 (ko) 1997-12-29
NO169123B (no) 1992-02-03
MY103801A (en) 1993-09-30
SE8900192D0 (sv) 1989-01-19
AU2867189A (en) 1989-07-20
SE8900192L (sv) 1989-07-21
PT89482B (pt) 1994-02-28
DK23489A (da) 1989-07-21
FI93546B (fi) 1995-01-13
FI890286A (fi) 1989-07-21
GB2217320A (en) 1989-10-25
GB2217320B (en) 1992-04-08
AT397801B (de) 1994-07-25
FR2626002B1 (fr) 1994-01-28
OA09031A (en) 1991-03-31
PL163814B1 (en) 1994-05-31
IE890153L (en) 1989-07-20
HUT48887A (en) 1989-07-28
IE62275B1 (en) 1995-01-25
PL277261A1 (en) 1989-09-18
CA1339896C (en) 1998-06-02
DK23489D0 (da) 1989-01-19
CH679152A5 (xx) 1991-12-31
DE3901502C2 (de) 2002-06-13
LU87437A1 (fr) 1989-08-30
NO890253D0 (no) 1989-01-19
ATA10689A (de) 1993-11-15
AU637015B2 (en) 1993-05-13
KR890011902A (ko) 1989-08-23
IL88999A0 (en) 1989-08-15
NO169123C (no) 1992-05-13
DK175131B1 (da) 2004-06-14
IT8947546A0 (it) 1989-01-19
FI890286A0 (fi) 1989-01-19
FR2626002A1 (fr) 1989-07-21
GB8901187D0 (en) 1989-03-15
JPH02196788A (ja) 1990-08-03
HU203755B (en) 1991-09-30
RU2114846C1 (ru) 1998-07-10
AU626278B2 (en) 1992-07-30
BE1003815A4 (fr) 1992-06-23
GR890100033A (el) 1994-03-31
YU12389A (en) 1991-10-31
YU47791B (sr) 1996-01-09
AU1018092A (en) 1992-03-12
NL8900122A (nl) 1989-08-16
FI93546C (fi) 1995-04-25
DE3901502A1 (de) 1989-07-27
JP2793825B2 (ja) 1998-09-03
SE505213C2 (sv) 1997-07-14
NO890253L (no) 1989-07-21
IL88999A (en) 1994-12-29
NZ227663A (en) 1990-09-26
PT89482A (pt) 1989-10-04
ES2010091A6 (es) 1989-10-16

Similar Documents

Publication Publication Date Title
IT1229531B (it) Composti nucleosidi dideossidideidrocarbociclici e formulazione farmaceutica che li contiene
DE10199066I1 (de) Pharmazeutische Zusammensetzung
LV10573A (lv) Panemiens farmaceitiska sastava iegusanai
DE3486441D1 (de) 3-Hydroxypyrid-4-one und pharmazeutische Zusammensetzungen
DK481989D0 (da) Farmaceutiske formuleringer
DE122004000023I2 (de) Pharmazeutische Zusammensetzung
DK229489D0 (da) Laegemiddeladsorbater
SE8801813L (sv) Pharmaceutical composition
KR890701101A (ko) 제약학적 조성물
DK619987D0 (da) Galenisk formulering
KR880701541A (ko) 마이크로 캡슐을 포함하는 제약학적 배합물
FR2636532B1 (fr) Compositions pharmaceutiques
DK489189D0 (da) Farmaceutisk praeparat
DK548689A (da) Farmaceutisk oploesning
DK603988D0 (da) Farmaceutisk praeparat
DK256290A (da) Farmaceutisk praeparat indeholdende deoxyribonucleosider til saarheling
MX5577A (es) Formulacion farmaceutica
DK336489A (da) Farmaceutisk praeparat
DK142487A (da) Farmaceutiske midler
DK0511991T3 (da) Farmaceutisk formulering
ATA133288A (de) Pharmazeutische zusammensetzung
IT1200467B (it) Formulazione farmaceutica
DK37589D0 (da) Farmaceutisk praeparat for 4-aroylimidazol-2-oner
IT1224244B (it) Composizione farmaceutica anoressizzante comprendente 5-idrossitrpofano
ATA246089A (de) Pharmazeutische zusammensetzung enthaltend phenylcarbamate

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19990128